Auna (AUNA) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Jun, 2026Executive summary
Third quarter consolidated revenue was S/1,117 million, up 1% FX-neutral but down 1% YoY, with strong local currency growth in Peru (+9%) and Colombia (+4%) offset by a 12% decline in Mexico.
Adjusted EBITDA declined 7% YoY to S/232 million, margin down 1.3 p.p. to 20.8%, mainly due to Mexico's performance, while Peru and Colombia delivered robust growth.
Adjusted Net Income was S/58 million, down from S/75 million in 3Q24, with positive operating profit in all segments except Mexico.
Leverage ratio remained stable at 3.6x, with a medium-term target below 3x and a healthy cash position post successful debt refinancing.
Strategic initiatives in Mexico include leadership changes, IT upgrades, and a partnership with Sojitz to accelerate recovery, with growth expected to resume in 2026.
Financial highlights
Consolidated FX-neutral revenue increased 1% YoY, driven by 9% growth in Peru and 4% in Colombia, offset by a 12% decline in Mexico.
Adjusted EBITDA was S/232 million, down 7% YoY, with margin at 20.8% (-1.3 p.p. YoY).
Adjusted Net Income was S/58 million for the quarter.
Free cash flow reached S/321 million, with pre-tax operating cash flow up 65% sequentially.
Net debt at S/3,429 million, with cash position at S/226 million at quarter-end.
Outlook and guidance
Growth in Mexico is expected to resume in early 2026 as strategic initiatives and IT system implementations progress.
Management targets leverage below 3x net debt to EBITDA in the medium term.
Strategic partnership with Sojitz includes a planned US$500 million investment in Mexico over 3–5 years.
Latest events from Auna
- Adjusted EBITDA up 31% YoY, revenue up 18% YoY, and leverage ratio improved to 4.13x.AUNA
Q2 20248 Jul 2026 - Revenue up 13% YoY, strong cash flow, margin down, guidance reaffirmed.AUNA
Q1 202622 May 2026 - FY25 saw strong cash flow, Peru and Colombia growth, and a 12% FXN growth target for 2026.AUNA
Q4 202511 Mar 2026 - Adjusted EBITDA up 23% YoY, leverage ratio at 3.7x, and OncoMexico pilot advancing.AUNA
Q3 202413 Jan 2026 - Healthcare group targets $1B NYSE offering to expand Latin American operations.AUNA
Registration Filing16 Dec 2025 - Healthcare group seeks up to $1B in NYSE-listed shares to fund growth in Latin America.AUNA
Registration Filing16 Dec 2025 - FY24 Adjusted EBITDA up 20.1% FXN, margin and net income improved, leverage at 3.6x.AUNA
Q4 20243 Dec 2025 - Peru's growth offset Mexico and Colombia's declines, sustaining profitability and stable leverage.AUNA
Q1 202526 Nov 2025 - Adjusted EBITDA up 5% FXN YoY; net income surged; leverage steady amid FX headwinds.AUNA
Q2 202523 Nov 2025